Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning SPH Herbpex Pharmaceutical (Group) Co., Ltd. (formerly known as Liaoning Haohushi Pharmaceutical) is a prominent Chinese pharmaceutical company specializing in the research, development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) and modern herbal preparations. Founded in 1999 and headquartered in Benxi, Liaoning Province, the company is a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). Its extensive product portfolio includes well-known commercialized TCM products such as Rupixiao Pian for breast hyperplasia and mastitis, and Wang Bi tablets for rheumatoid arthritis and joint disorders. The company operates large-scale GMP-compliant manufacturing facilities and maintains extensive raw material cultivation bases across China to ensure the quality and traceability of its botanical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Haohushi Pharmaceuticals.